Ann: Change of Director's Interest Notice - J Basile, page-2

Great, Mr Basile bought some at $11.99/share.



Mr Joe Basile, FIPA, FFA
Non-Executive Director
Joe joined the Neuren Board in 2023. He has held a number of executive roles in the pharmaceutical industry for over 30 years, most recently as Group CFO at iNova Pharmaceuticals based in Singapore and prior to that with Novartis in senior Finance leadership and Commercial Sales leadership roles in Australia and Asia.


TPG Capital to buy iNova for $2b-plus; PEP to co-invest
Anthony Macdonald, Sarah Thompson and Kanika Sood
Updated Jul 26, 2022 – 2.21pm,first published at 11.07am

Private equity firm TPG Capital’s Aussie hot-streak is gaining steam, with the group set to acquire medicine and healthcare products company iNova Pharmaceuticals.